HELPING THE OTHERS REALIZE THE ADVANTAGES OF ABBV-744 IN CLINICAL TRIALS FOR NON-SMALL CELL LUNG CANCER (NSCLC)

Additional studies in progress suggest that ARV-825 may also be effective in boosting the response to estrogen deprivation (aromatase inhibition), another ingredient of standard of treatment in ER+ breast cancer.- "Our study exposed the vital part in the KLF16/MYC regulatory axis in modulating tumor progress and chemotherapy sensitivity in BLCA, su